Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing alpha or beta amino acid or substituted amino acid...
Reexamination Certificate
2001-07-30
2004-11-30
Patterson, Jr., Charles L. (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing alpha or beta amino acid or substituted amino acid...
C435S195000, C514S477000
Reexamination Certificate
active
06825014
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed towards the preparation of compounds of the general formula (I):
Such compounds are prepared in particular by means of an enzymatic process from hydantoins of the general formula (II):
2. Description of Related Art
Compounds of formula (I) are suitable intermediates for the preparation of pharmaceuticals described in U.S. Pat. No. 5552397, WO 9738705 and in J. Med. Chem. 42, 305 (1999).
J. Med. Chem. 42, 305 (1999) mentions a synthesis route for the preparation of a structural unit—an &agr;-amino-&egr;-caprolactam derivative—of the pharmaceutically active compounds. However, that structural unit is obtained with the aid of expensive reagents in a process that is rather disadvantageous for a robust commercial process.
The preparation of compounds such as (I) from hydantoins such as (II) by means of
Arthrobacter
sp. is already known from JP 99206397. However, that document does not describe the advantageous racemisation.
The conversion of hydantoins by means of hydantoinases and specific carbamoylases is already known from DE19529211.1. The spontaneous chemical racemisation of hydantoins for the preparation of enantiomerically enriched amino acids is to be found in DE-P4137581.5-44.
BRIEF DESCRIPTION OF THE INVENTION
Accordingly, one object of the present invention is to provide an enzymatic process for the preparation of the desired compounds of formulae (I), that is a simpler, more efficient, and less costly process suitable for large-scale commercial or industrial applications.
Another object of the invention is to provide a process for providing an allysine acetal in high yield and with a high degree of optical purity, for instance L-allysine acetal in a yield of about 85% or more, preferably at least 90% and most preferably >95%, and with an optical purity of at least 90%, preferably at least 95%, and most preferably >99% ee.
Yet another object of the invention is to provide a process that uses a total cell catalyst comprising a cell that has a gene encoding a hydantoin racemase, a hydantoinase and an L- or D-specific carbamoylase. For instance, a total cell catalyst comprising an L-specific carbamoylase.
Products and compositions comprising compounds of general formulae (I) and having a high degree of optical purity are advantageously used as intermediates for producing pharmacologically active products, or directly in pharmacological products.
Other objects of the invention are described or may be inferred from the following detailed description.
REFERENCES:
patent: 0 625 571 (1994-11-01), None
patent: 11-206397 (1999-08-01), None
patent: WO 00/58449 (2000-10-01), None
patent: WO 01/23535 (2001-04-01), None
patent: WO 01/23582 (2001-04-01), None
Pietzsch, M., et al. (2000) J. Chromatog. B 737, 179-186.*
Syldatk, C., et al. (1988) Ann. N.Y. Acad. Sci. 542, 323-329.*
O. May, et al., Nature Biotechnology, vol. 18, No. 3, pp. 317-320, “Inverting Enantioselectivity by Directed Evolution of Hydantoinase for Improved Production of L-Methionine”, Mar. 2000.
G. Wohlfahrt, et al., Dechema Biotechnology Conferences, vol. 5, No. Part A, pp. 45-48, “Immobilization of Hydantoin Cleaving Enzymes”, 1992.
A. S. Bommarius, et al., Chirality, pp. 371-391, “Membrane Bioreactors for the Production of Enantiomerically Pure &agr;-Amino Acids”, 1992.
Drauz Karlheinz
Klement Ingo
Krimmer Hans-Peter
May Oliver
Reichert Dietmar
Degussa - AG
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Patterson Jr. Charles L.
LandOfFree
Process for the preparation of allysine acetal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of allysine acetal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of allysine acetal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3344952